Recorded Presentations from the NCCN 2025 Annual Congress: Hematologic Malignancies™

This congress focuses on updates to the NCCN Guidelines®, new and emerging therapeutic agents, and practical management strategies to ensure optimal patient outcomes.

Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with chronic lymphocytic leukemia (CLL).
Approaches to Individualized Treatment for Chronic Lymphocytic Leukemia: Expert Guidance on Sequencing Therapy, Novel Agents, and their Combinations

The goal of this program is to improve the knowledge and competence of clinicians to implement best practices in the treatment of CLL.

 

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Recorded Presentation of NCCN Optimizing Patient Outcomes - When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia

Management of Richter transformation (RT) with conventional chemotherapy is largely met with poor responses and short survival.

NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026

Bruton tyrosine kinase inhibitors (BTKis) and BCL2 inhibitor (BCL2i)–containing regimens significantly improve survival outcomes in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Archived NCCN Tumor Boards: Challenges in Management of Chronic Lymphocytic Leukemia-Richter Transformation
This activity will help you navigate the unique complexities of managing Richter transformation, while keeping you up to date on the latest advances and emerging therapies. You will gain practical insights to identify the right patients for novel treatments, integrate new approaches into care, and recognize when referral to clinical trials can offer the best outcomes.
NCCN Optimizing Patient Outcomes - When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia

Management of Richter transformation (RT) with conventional chemotherapy is largely met with poor responses and short survival.

Aligning Discovery With Clinical Practice: Applying Expert Consensus Guidelines to Improve Patient Outcomes in CLL/SLL

Click the Register/Take Course button to complete the evaluation and get your certificate.

Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course (Encore Webinar)
Join us for this dynamic, case-based, live webinar in collaboration with Clinical Care Options to hear from an expert panel on current recommendations and emerging strategies for treating patients with CLL.
NCCN Tumor Boards: Challenges in Management of Chronic Lymphocytic Leukemia-Richter Transformation
This activity will help you navigate the unique complexities of managing Richter transformation, while keeping you up to date on the latest advances and emerging therapies. You will gain practical insights to identify the right patients for novel treatments, integrate new approaches into care, and recognize when referral to clinical trials can offer the best outcomes.

Pages

Subscribe to RSS - Chronic Lymphocytic Leukemia